3- 2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-1-AZETIDINE CARBOXAMIDES HAVING ANTICONVULSANT ACTIVITY
申请人:A.H. ROBINS COMPANY, INCORPORATED
公开号:EP0560905A1
公开(公告)日:1993-09-22
US5095014A
申请人:——
公开号:US5095014A
公开(公告)日:1992-03-10
[EN] 3-(2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY)-1-AZETIDINE CARBOXAMIDES HAVING ANTICONVULSANT ACTIVITY
申请人:——
公开号:WO1992010474A1
公开(公告)日:1992-06-25
[FR] L'invention se rapporte à de nouveaux carboxamides de 3-(2-chloro-4-trifluorométhylphénoxy)-1-azétidine, représentés par la formule (I), où R1 et R2, qui peuvent être identiques ou différents, sont choisis parmi hydrogène, alkyle C1-C4 et allyle. Dans une série de carboxamides de 3-(phénoxy substitué)-1-azétidine, l'introduction d'un atome de chlore à la position 2 du groupe phénoxy des carboxamides de 4-trifluorométhylphénoxy-1-azétidine correspondants s'est traduite dans des tests pharmacologiques par une augmentation inattendue de la puissance anticonvulsive de ces composés. [EN] The present invention relates to novel 3-(2-chloro-4-trifluoromethylphenoxy)-1-azetidine carboxamides having formula (I), wherein R?1 and R?2, same or different, are selected from hydrogen, C1?-C4? alkyl, and allyl. In a series of 3-(substituted phenoxy)-1-azetidinecarboxamides, introduction of a chlorine atom at the 2-position of the phenoxy group of the corresponding 4-trifluoromethylphenoxy-1-azetidinecarboxamides resulted in unexpected increased potency in anticonvulsant pharmacological tests.
3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having
申请人:A. H. Robins Company, Incorporated
公开号:US05095014A1
公开(公告)日:1992-03-10
The present invention relates to novel 3-(2-chlor-4-trifluoromethylphenoxy)-1-azetidine carboxamides having the formula: ##STR1## wherein R1 and R2, same or different, are selected from hydrogen, C.sub.1 -C.sub.4 alkyl, and allyl. In a series of 3-(substitutedphenoxy)-1-azetidinecarboxamides, introduction of a chlorine atom at the 2-position of the phenoxy group of the corresponding 4-trifluoromethylphenoxy-1-azetidinecarboxamides resulted in unexpected increased potency in anticonvulsant pharmacological tests.